Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Scandinavian Journal of Gastroenterology|November 6, 2018
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapyHege Kileng, Midori Kjellin, Dario Akaberi, et al.Scandinavian Journal of Gastroenterology|August 20, 2019
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and NorwayMidori Kjellin, Hege Kileng, Dario Akaberi, et al.Antimicrobial Agents and Chemotherapy|March 2, 2011
Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptaseRaymond F Schinazi, Ivana Massud, Kimberly L Rapp, et al.Plos One|September 21, 2011
Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallardsJosef D Järhult, Shaman Muradrasoli, John Wahlgren, et al.Viruses|August 28, 2021
SHARED: An International Collaboration to Unravel Hepatitis C ResistanceAnita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, et al.Antimicrobial Agents and Chemotherapy|August 28, 2024
Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical librariesDario Akaberi, Monireh Pourghasemi Lati, Janina Krambrich, et al.Hepatology Communications|February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic reviewSofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.Journal of the American Chemical Society|February 10, 2022
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against CoronavirusesAndreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.Pageof 4